Astrazeneca (AZN) Current Taxes (2009 - 2026)

Astrazeneca's Current Taxes history runs 18 years deep, the most recent figure standing at -$1.3 billion for Q1 2026.

• In Q1 2026, Current Taxes rose 21.56% year-over-year to -$1.3 billion; the TTM figure through Mar 2026 stood at -$1.3 billion (up 21.56% YoY), while the FY2025 annual figure was -$1.1 billion, down 177.1% from the prior year.
• Current Taxes was -$1.3 billion for Q1 2026 at Astrazeneca, down from -$1.1 billion in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $1.6 billion in Q4 2023 to a low of -$1.7 billion in Q1 2025.
• Historically, Current Taxes has averaged -$837.5 million across 5 years, with a median of -$1.2 billion in 2023.
• The sharpest annual moves came in 2023 and 2025: Current Taxes soared 76.79% in 2023, then tumbled 177.1% in 2025.
• A 5-year view of Current Taxes shows it stood at $896.0 million in 2022, then surged by 76.79% to $1.6 billion in 2023, then decreased by 11.24% to $1.4 billion in 2024, then tumbled by 177.1% to -$1.1 billion in 2025, then declined by 19.83% to -$1.3 billion in 2026.
• The last three Current Taxes figures came in at -$1.3 billion (Q1 2026), -$1.1 billion (Q4 2025), and -$1.3 billion (Q3 2025), per Business Quant data.